Return to study ST000422 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

SelectMetabolite Name Metabolite Id Refmet Name Ret. Index Quant. m/z Analysis Display
1-(9Z-hexadecenoyl)-2-(9Z,12Z-heptadecadienoyl)-sn... ME144419 DG 16:1_17:2 --HILIC NEGATIVE ION MODE
1-(9Z-hexadecenoyl)-2-(9Z,12Z-heptadecadienoyl)-sn... ME142559 DG 16:1_17:2 --HILIC POSITIVE ION MODE
1-(13Z-docosenoyl)-2-(7Z,10Z,13Z,16Z,19Z-docosapen... ME148710 DG 22:1_22:5 --Reversed phase NEGATIVE ION MODE
1,2-di-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycerol ME148628 DG 20:3_20:3 --Reversed phase NEGATIVE ION MODE
1-(9Z-hexadecenoyl)-2-(9Z,12Z-heptadecadienoyl)-sn... ME147504 DG 16:1_17:2 --Reversed phase POSITIVE ION MODE
1-(9Z-hexadecenoyl)-2-(9Z,12Z-heptadecadienoyl)-sn... ME147526 DG 16:1_17:2 --Reversed phase POSITIVE ION MODE
1-(9Z-hexadecenoyl)-2-(9Z,12Z-heptadecadienoyl)-sn... ME147608 DG 16:1_17:2 --Reversed phase POSITIVE ION MODE


  logo